Cough-Cold and Flu

PARSIPPANY, N.J. – While the U.S. OTC market is not highly dynamic in terms of growth, its competitive landscape has changed significantly over the past five years, with the top 10 rankings shifting in 2015, the Kline Group noted on Monday from its recently published Nonprescription Drugs USA.

ALEXANDRIA, Va. - The National Community Pharmacists Association on Tuesday announced its 2016 lineup of one-day seminars to help community pharmacy owners and front-end staff hone their merchandising and marketing skills, as well as a new sponsorship by Good Neighbor Pharmacy and AmerisourceBergen Drug Corporation to continue the Front-End Profit Building Seminars program.

WASHINGTON —  Since the Food and Drug Administration’s March 25, 2014 Part 15 public hearing on the OTC Drug Monograph, the Consumer Healthcare Products Association has been in discussions with FDA and relevant committees in Congress to identify potential enhancements that would update and modernize this regulatory framework for most nonprescription medicines.

MERIDEN, Conn. - Protein Sciences Corporation on Tuesday announced that FDA has approved the 2016/17 formulation of Flublok influenza vaccine.   

FDA approval of the 2016/17 formulation of Flublok means that Flublok is on track to ship to healthcare providers in early August.     

STOCKHOLM - Moberg Pharma on Friday announced that the acquisition of three over-the-counter brands from Prestige Brands has been completed as part of a deal worth $40 million.

CEDAR RAPIDS, Iowa - Eco Lips, a lip balm company specializing in certified organic lip balm products, on Wednesday announced a new charitable initiative with Pencils of Promise, a for-purpose organization founded in 2008 that to date has built more than 360 schools and provided access to education to more than 33,000 students throughout Africa, Asia and Latin America.

STOCKHOLM -- Moberg Pharma has signed an agreement to acquire U.S. OTC brands New Skin, Fiber Choice and PediaCare from Prestige Brands, Inc.

The purchase price is $40 million and the acquired brands will be sold through Moberg’s current OTC channel in the U.S, primarily in drugstores such as CVS, Walgreens and Rite Aid and in mass retailers such as Walmart and Target.